Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Magnitude 6.1 earthquake jolts eastern Taiwan
04/27/2024 02:54 AM - Politics
A discussion with Cosette Wu, the woman behind the Harvard speech disruption
04/26/2024 11:25 PM - Society
32 indicted in NT$800 million crypto fraud case
04/26/2024 10:50 PM - Business
Taiwan, U.S. to hold new round of trade talks in Taipei next week: Office
04/26/2024 10:18 PM - Culture
Budapest picked as 2024 Taipei Film Festival's 'City in Focus'
04/26/2024 10:00 PM